CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Dexcom G6 Continuous Glucose Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04721145
NCT04721145N/ACompleted
CompareCT.gov

IMPaCT: IMPlementing Continuous Glucose Monitoring in High-risk, Poorly Controlled Children With Type 1 Diabetes

Johns Hopkins University·interventional·Posted Jan 22, 2021·Updated Aug 4, 2023

In Brief

A clinical study evaluating Dexcom G6 Continuous Glucose Monitor for Type 1 Diabetes and 2 related conditions. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes, Hypoglycemia, High Blood Sugar
CountriesUnited States
CollaboratorsDexCom, Inc.

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 22, 2021
Enrollment StartJan 25, 2021
Primary CompletionJun 28, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.4 years ago

Interventions

Dexcom G6 Continuous Glucose Monitordevice

Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.